Abstract: The invention provides a novel prostate dilation catheter, which comprises a main tube, wherein a urinary catheterization cavity, an internal capsule cavity, an external capsule cavity and a flushing cavity are provided inside the main tube, a composite bar-like high pressure water capsule is arranged in front portions of an outlet of the urinary catheterization cavity and an outlet of the flushing cavity, the composite bar-like high pressure water capsule comprises an internal capsule and an external capsule, the internal capsule is arranged inside the outer capsule and at a front end of the outer capsule, and the front ends of the internal capsule cavity and the external capsule cavity are formed with openings which are located inside the internal capsule and the external capsule respectively.

Abstract: The invention provides for methods of monitoring the proliferation of cultured prostate cancer cells in the presence of quercetin, methods of treating an individual with prostate cancer or at risk of developing prostate cancer, and methods of reducing the risk of recurrence of prostate cancer in an individual who had previously been treated for prostate cancer. Methods of the invention further include treating an individual with benign prostatic hyperplasia (BPH) with quercetin as well as methods of screening for compounds that inhibit the proliferation of prostate cancer cells. The invention provides for compositions and articles of manufacture containing quercetin in particular formulations, and quercetin with a second compound that also exerts an effect on the androgen receptor.

Abstract: The invention provides for methods of monitoring the proliferation of cultured prostate cancer cells in the presence of quercetin, methods of treating an individual with prostate cancer or at risk of developing prostate cancer, and methods of reducing the risk of recurrence of prostate cancer in an individual who had previously been treated for prostate cancer. Methods of the invention further include treating an individual with benign prostatic hyperplasia (BPH) with quercetin as well as methods of screening for compounds that inhibit the proliferation of prostate cancer cells. The invention provides for compositions and articles of manufacture containing quercetin in particular formulations, and quercetin with a second compound that also exerts an effect on the androgen receptor.